AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Revvity Inc. (RVTY)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

111.41

-0.85 (-0.76%)

At close: Feb 18, 2025, 3:59 PM

111.74

0.30%

After-hours: Feb 18, 2025, 04:11 PM EST

undefined% (undefined)

Bid	109.31
Market Cap	13.56B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	2.3
PE Ratio (ttm)	48.44
Forward PE	n/a
Analyst	Buy

Ask	118.78
Volume	430,575
Avg. Volume (20D)	884,433
Open	112.54
Previous Close	112.26
Day's Range	110.99 - 113.55
52-Week Range	97.32 - 129.50
Beta	undefined

About RVTY

Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection, and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences resea...

[Show more]

Industry Medical - Diagnostics & Research

Sector Healthcare

IPO Date Jul 6, 1965

Employees 11,000

Stock Exchange NYSE

Ticker Symbol RVTY

Website https://www.perkinelmer.com

Full Company Profile

Analyst Forecast

According to 11 analyst ratings, the average rating for RVTY stock is "Buy." The 12-month stock price forecast is $140, which is an increase of 25.66% from the latest price.

Buy 72.73%

Hold 27.27%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Revvity Inc. is scheduled to release its earnings on Apr 28, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 month ago

+7.74%

Revvity shares are trading higher after the compan... Unlock content with Pro Subscription

6 months ago

+9.07%

Revvity shares are trading higher after the company reported strong Q2 earnings and raised its guidance.

News

2 weeks ago · zacks.com

RVTY Q4 Earnings Beat Estimates, Sales Miss, Segments Robust

Revvity's fourth-quarter results showcase strong growth in Diagnostics business, along with recovery in Life Sciences segmental sales.

2 weeks ago · zacks.com

Revvity (RVTY) Reports Q4 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Revvity (RVTY) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compar...

2 weeks ago · seekingalpha.com

Revvity, Inc. (RVTY) Q4 2024 Earnings Call Transcript

Revvity, Inc. (NYSE:RVTY ) Q4 2024 Earnings Conference Call January 31, 2025 8:00 AM ET Company Participants Steve Willoughby - Senior Vice President, Investor Relations Prahlad Singh - President & Ch...

2 weeks ago · zacks.com

Revvity (RVTY) Surpasses Q4 Earnings Estimates

Revvity (RVTY) came out with quarterly earnings of $1.42 per share, beating the Zacks Consensus Estimate of $1.36 per share. This compares to earnings of $1.25 per share a year ago.

2 weeks ago · reuters.com

Revvity forecasts 2025 revenue, profit below estimates amid weak biotech spending

Medical equipment maker Revvity forecast full-year profit and revenue for 2025 below Wall Street estimates on Friday, as it expects soft demand for its products and services used in drug research.

2 weeks ago · businesswire.com

Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2024

WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY) today reported financial results for the fourth quarter and full year ended December 29, 2024. Fourth Quarter 2024 The Company reported GAAP...

2 weeks ago · zacks.com

Revvity Gears Up for Q4 Earnings: What's in the Offing?

RVTY's fourth-quarter results are likely to reflect decent performance in the Diagnostics segment. The Life Sciences segment is likely to have faced continued challenges in China.

3 weeks ago · zacks.com

Revvity (RVTY) Earnings Expected to Grow: Should You Buy?

Revvity (RVTY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 weeks ago · zacks.com

Will Revvity (RVTY) Beat Estimates Again in Its Next Earnings Report?

Revvity (RVTY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

3 weeks ago · businesswire.com

Revvity Ignites Scientific Breakthroughs at SLAS2025

WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. is set to unveil its groundbreaking new Phenologic.AI™ software at SLAS2025 in San Diego, January 27-29. Designed to redefine cellular imaging workflows ...

Load More News